1. Home
  2. RCMT vs SGMO Comparison

RCMT vs SGMO Comparison

Compare RCMT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$27.50

Market Cap

140.8M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
SGMO
Founded
1971
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
141.2M
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
RCMT
SGMO
Price
$27.50
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.00
AVG Volume (30 Days)
60.1K
6.8M
Earning Date
04-03-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
10.20
EPS
2.14
N/A
Revenue
$186,737,000.00
$36,567,000.00
Revenue This Year
$16.29
$24.46
Revenue Next Year
$6.92
$193.67
P/E Ratio
$12.73
N/A
Revenue Growth
5.83
88.60
52 Week Low
$15.29
$0.21
52 Week High
$28.19
$0.84

Technical Indicators

Market Signals
Indicator
RCMT
SGMO
Relative Strength Index (RSI) 82.25 33.87
Support Level $26.23 $0.21
Resistance Level N/A $0.55
Average True Range (ATR) 1.34 0.04
MACD 0.98 -0.01
Stochastic Oscillator 96.68 24.14

Price Performance

Historical Comparison
RCMT
SGMO

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: